NEW YORK (GenomeWeb) – KeyGene today announced it has licensed its sequencing-based genotyping technology to the University of Edinburgh for research purposes.

The license includes access to and use of KeyGene's restricted-site associated DNA sequencing technology. The SBG technology enables the discovery and scoring of genetic variation for improving crops without prior knowledge of the genome sequence and provides researchers with a method to conduct genome-wide SNP discovery and genotyping in a single experiment, KeyGene said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.